<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04791540</url>
  </required_header>
  <id_info>
    <org_study_id>SARCOBIA1_FDG</org_study_id>
    <nct_id>NCT04791540</nct_id>
  </id_info>
  <brief_title>Sarcopenia and Nutritional Status in a Rehabilitation Setting</brief_title>
  <official_title>Observational Pilot Study in Patients Who Underwent Tracheostomy: Sarcopenia Assessment by Handgrip Strenght and BIA. Association to Malnutrion Risk, Nutritional Status, Gut Microbioma and Decannulation Time.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fondazione Don Carlo Gnocchi Onlus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Florence</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Fondazione Don Carlo Gnocchi Onlus</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this pilot observational study the primary outcome is to assess, in a Respiratory&#xD;
      Rehabilitation Unit, if there is an association between sarcopenia, assessed by handgrip&#xD;
      strenght and BIA, and a delayed decannulation time in patients who underwent tracheostomy.&#xD;
&#xD;
      Secondary outcomes are to assess if there is an association between an increased malnutrition&#xD;
      risk (assessed by MUST), a poor nutritional status (assessed by GLIM criteria) and a delayed&#xD;
      decannulation time and the gut microbiota composition.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 9, 2021</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change from admission in muscle mass at decannulation time</measure>
    <time_frame>Respiratory Rehabilitation Unit admission (T0) and decannulation time (T1), an average of 10 days</time_frame>
    <description>Measurement of muscle mass with Bioelectrical Impedance Analysis (BIA).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from admission in hangrip strenght at decannulation time</measure>
    <time_frame>Respiratory Rehabiliation Unit admission (T0) and decannulation time (T1), an average of 10 days</time_frame>
    <description>Measurement of handgrip strenght with a handheld dynamometer. Male cut-off: &lt;27 Kg Female cut-off: &lt;16 Kg</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from admission in Body Mass Index (BMI) score at decannulation time</measure>
    <time_frame>Respiratory Rehabiliation Unit admission (T0) and decannulation time (T1), an average of 10 days</time_frame>
    <description>Measurement of height and weight to get a BMI score (weight/(height^2). BMI &lt;18.5 Kg/m^2: underweight BMI 18.5-24.9 Kg/m^2: normal range BMI 25.0-29.9 Kg/m^2: overweight BMI 30.0-34.9 Kg/m^2 obese class I BMI 35.0-39.9 Kg/m^2 obese class II BMI &gt;= 40 Kg/m^2 obese class III</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from admission in Malnutrition Universal Screening Tool (MUST) score at decannulation time</measure>
    <time_frame>Respiratory Rehabiliation Unit admission (T0) and decannulation time (T1), an average of 10 days</time_frame>
    <description>MUST is a screening tool to identify adults who are malnourished, at risk of malnutrition or obese.&#xD;
score 0: low risk score 1: medium risk score 2 or more: high risk</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from admission in nutritional status at decannulation time</measure>
    <time_frame>Respiratory Rehabiliation Unit admission (T0) and decannulation time (T1), an average of 10 days</time_frame>
    <description>Global Leadership Initiative on Malnutrition (GLIM) criteria are 5 diagnostic criteria to assess malnutrition that include 3 phenotypic (weight loss, low body mass index and reduced muscle mass) and 2 etiologic (reduced food intake/assimilation, and inflammation/disease burden) criteria.&#xD;
To diagnose malnutrition at least 1 phenotypic criterion and 1 etiologic criterion should be present.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from admission in Gut Microbiota (GM) composition at decannulation time</measure>
    <time_frame>Respiratory Rehabiliation Unit admission (T0) and decannulation time (T1), an average of 10 days</time_frame>
    <description>Gut Microbiota (GM) composition</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Protein C reactive (PCR)</measure>
    <time_frame>Respiratory Rehabiliation Unit admission (T0) and decannulation time (T1), an average of 10 days</time_frame>
    <description>Change from admission in Protein C reactive (PCR) at decannulation time</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lymphocyte count</measure>
    <time_frame>Respiratory Rehabiliation Unit admission (T0) and decannulation time (T1), an average of 10 days</time_frame>
    <description>Change from admission in lymphocyte count at decannulation time</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Creatinine</measure>
    <time_frame>Respiratory Rehabiliation Unit admission (T0) and decannulation time (T1), an average of 10 days</time_frame>
    <description>Change from admission in creatinine at decannulation time</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Creatine Poshokinase</measure>
    <time_frame>Respiratory Rehabiliation Unit admission (T0) and decannulation time (T1), an average of 10 days</time_frame>
    <description>Change from admission in creatine poshokinase at decannulation time</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total serum protein</measure>
    <time_frame>Respiratory Rehabiliation Unit admission (T0) and decannulation time (T1), an average of 10 days</time_frame>
    <description>Change from admission in total serum protein at decannulation time</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Albumin</measure>
    <time_frame>Respiratory Rehabiliation Unit admission (T0) and decannulation time (T1), an average of 10 days</time_frame>
    <description>Change from admission in albumin at decannulation time</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vitamin (25OH) D</measure>
    <time_frame>Respiratory Rehabiliation Unit admission (T0) and decannulation time (T1), an average of 10 days</time_frame>
    <description>Change from admission in vitamin (25OH) D at decannulation time</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Selenium</measure>
    <time_frame>Respiratory Rehabiliation Unit admission (T0) and decannulation time (T1), an average of 10 days</time_frame>
    <description>Change from admission in selenium at decannulation time</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Leptin</measure>
    <time_frame>Respiratory Rehabiliation Unit admission (T0) and decannulation time (T1), an average of 10 days</time_frame>
    <description>Change from admission in leptin at decannulation time</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Uric Acid</measure>
    <time_frame>Respiratory Rehabiliation Unit admission (T0) and decannulation time (T1), an average of 10 days</time_frame>
    <description>Change from admission in uric acid at decannulation time</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Magnesium</measure>
    <time_frame>Respiratory Rehabiliation Unit admission (T0) and decannulation time (T1), an average of 10 days</time_frame>
    <description>Change from admission in magnesium at decannulation time</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Growth Hormone (GH)</measure>
    <time_frame>Respiratory Rehabiliation Unit admission (T0) and decannulation time (T1), an average of 10 days</time_frame>
    <description>Change from admission in growth hormone at decannulation time</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Insuline-like Growth Factor-1 (IGF-1)</measure>
    <time_frame>Respiratory Rehabiliation Unit admission (T0) and decannulation time (T1), an average of 10 days</time_frame>
    <description>Change from admission in Insuline-like Growth Factor-1 (IGF-1) at decannulation time</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dehydroepiandrosterone (DHEA)</measure>
    <time_frame>Respiratory Rehabiliation Unit admission (T0) and decannulation time (T1), an average of 10 days</time_frame>
    <description>Change from admission in dehydroepiandrosterone (DHEA) at decannulation time</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Testosterone</measure>
    <time_frame>Respiratory Rehabiliation Unit admission (T0) and decannulation time (T1), an average of 10 days</time_frame>
    <description>Change from admission in testosterone at decannulation time</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pro-inflammatory cytokine interleukin IL-6</measure>
    <time_frame>Respiratory Rehabiliation Unit admission (T0) and decannulation time (T1), an average of 10 days</time_frame>
    <description>Change from admission in pro-inflammatory cytokine interleukinIL-6 at decannulation time</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tumor Necrosis Factor-α (TNF-α)</measure>
    <time_frame>Respiratory Rehabiliation Unit admission (T0) and decannulation time (T1), an average of 10 days</time_frame>
    <description>Change from admission in Tumor Necrosis Factor-α (TNF-α) at decannulation time</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Sarcopenia</condition>
  <arm_group>
    <arm_group_label>Patients with trachestomy</arm_group_label>
    <description>Patients, attending a respiratory rehabilitation program, who underwent tracheostomy decannulation</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>handgrip strenght</intervention_name>
    <description>Muscle strenght measured with a handheld dynamometer, at admission (T0) and at decannulation time (T1)</description>
    <arm_group_label>Patients with trachestomy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Bioelectrical Impedance Analysis (BIA)</intervention_name>
    <description>Muscle mass evaluated by Bioelectrical Impedance Analysis (BIA), at admission (T0) and at decannulation time (T1)</description>
    <arm_group_label>Patients with trachestomy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>MUST</intervention_name>
    <description>Malnutrition risk assessed by Malnutrition Universal Screening Tool (MUST), at admission (T0) and at decannulation time (T1)</description>
    <arm_group_label>Patients with trachestomy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>GLIM</intervention_name>
    <description>Malnutrition diagnosis performed by Global Leadership Initiative on Malnutrition (GLIM) criteria, at admission (T0) and at decannulation time (T1)</description>
    <arm_group_label>Patients with trachestomy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Gut microbiota</intervention_name>
    <description>A fecal sample obtained at admission (T0) and at decannulation time (T1)</description>
    <arm_group_label>Patients with trachestomy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Blood Sample</intervention_name>
    <description>A Blood sample obtained at admission (T0) and at decannulation time (T1)</description>
    <arm_group_label>Patients with trachestomy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Anthropometric measures</intervention_name>
    <description>Measurement of weight and height (assessed only at admission) to calculate the Body Mass Index (BMI), at admission (T0) and at decannulation time (T1)</description>
    <arm_group_label>Patients with trachestomy</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who underwent tracheostomy before admission, attending a rehabilitation program&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Signed informed consent from patients or legal guardians for patients unfit to plead&#xD;
&#xD;
          -  Presence of tracheostomy at admission&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Refusal&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Pace maker/implantable cardioverter&#xD;
&#xD;
          -  No legal guardians for patients unfit to plead&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chiara F Gheri, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fondazione Don Carlo Gnocchi Onlus</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Chiara F Gheri, MD</last_name>
    <phone>00390557393612</phone>
    <email>cgheri@dongnocchi.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>Fondazione Don Carlo Gnocchi</name>
      <address>
        <city>Firenze</city>
        <zip>50143</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chiara F Gheri, MD</last_name>
      <phone>00390557393612</phone>
      <email>cgheri@dongnocchi.it</email>
    </contact>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Cederholm T, Jensen GL, Correia MITD, Gonzalez MC, Fukushima R, Higashiguchi T, Baptista G, Barazzoni R, Blaauw R, Coats AJS, Crivelli AN, Evans DC, Gramlich L, Fuchs-Tarlovsky V, Keller H, Llido L, Malone A, Mogensen KM, Morley JE, Muscaritoli M, Nyulasi I, Pirlich M, Pisprasert V, de van der Schueren MAE, Siltharm S, Singer P, Tappenden K, Velasco N, Waitzberg D, Yamwong P, Yu J, Van Gossum A, Compher C; GLIM Core Leadership Committee, GLIM Working Group. GLIM criteria for the diagnosis of malnutrition - A consensus report from the global clinical nutrition community. J Cachexia Sarcopenia Muscle. 2019 Feb;10(1):207-217. doi: 10.1002/jcsm.12383.</citation>
    <PMID>30920778</PMID>
  </reference>
  <reference>
    <citation>Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T, Cooper C, Landi F, Rolland Y, Sayer AA, Schneider SM, Sieber CC, Topinkova E, Vandewoude M, Visser M, Zamboni M; Writing Group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2), and the Extended Group for EWGSOP2. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019 Jul 1;48(4):601. doi: 10.1093/ageing/afz046.</citation>
    <PMID>31081853</PMID>
  </reference>
  <reference>
    <citation>Kyle UG, Bosaeus I, De Lorenzo AD, Deurenberg P, Elia M, Manuel Gómez J, Lilienthal Heitmann B, Kent-Smith L, Melchior JC, Pirlich M, Scharfetter H, M W J Schols A, Pichard C; ESPEN. Bioelectrical impedance analysis-part II: utilization in clinical practice. Clin Nutr. 2004 Dec;23(6):1430-53.</citation>
    <PMID>15556267</PMID>
  </reference>
  <reference>
    <citation>Kutsukutsa J, Mashamba-Thompson TP, Saman Y. Tracheostomy decannulation methods and procedures in adults: a systematic scoping review protocol. Syst Rev. 2017 Dec 4;6(1):239. doi: 10.1186/s13643-017-0634-0.</citation>
    <PMID>29202866</PMID>
  </reference>
  <reference>
    <citation>Ticinesi A, Nouvenne A, Cerundolo N, Catania P, Prati B, Tana C, Meschi T. Gut Microbiota, Muscle Mass and Function in Aging: A Focus on Physical Frailty and Sarcopenia. Nutrients. 2019 Jul 17;11(7). pii: E1633. doi: 10.3390/nu11071633. Review.</citation>
    <PMID>31319564</PMID>
  </reference>
  <reference>
    <citation>Toptas M, Yalcin M, Akkoc İ, Demir E, Metin C, Savas Y, Kalyoncuoglu M, Can MM. The Relation between Sarcopenia and Mortality in Patients at Intensive Care Unit. Biomed Res Int. 2018 Feb 12;2018:5263208. doi: 10.1155/2018/5263208. eCollection 2018.</citation>
    <PMID>29789798</PMID>
  </reference>
  <reference>
    <citation>Prado CM, Purcell SA, Alish C, Pereira SL, Deutz NE, Heyland DK, Goodpaster BH, Tappenden KA, Heymsfield SB. Implications of low muscle mass across the continuum of care: a narrative review. Ann Med. 2018 Dec;50(8):675-693. doi: 10.1080/07853890.2018.1511918. Epub 2018 Sep 12. Review.</citation>
    <PMID>30169116</PMID>
  </reference>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>February 22, 2021</study_first_submitted>
  <study_first_submitted_qc>March 8, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 10, 2021</study_first_posted>
  <last_update_submitted>August 30, 2021</last_update_submitted>
  <last_update_submitted_qc>August 30, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 31, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>handgrip strenght</keyword>
  <keyword>bioelectrical impedance analysis (BIA)</keyword>
  <keyword>respiratory rehabilitation</keyword>
  <keyword>tracheostomy decannulation</keyword>
  <keyword>gut microbiota</keyword>
  <keyword>GLIM criteria</keyword>
  <keyword>MUST</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sarcopenia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

